Division of Nuclear Medicine, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy.
Division of Nuclear Medicine, Azienda Unità Sanitaria Locale, Reggio Emilia, Italy.
Q J Nucl Med Mol Imaging. 2022 Mar;66(1):43-51. doi: 10.23736/S1824-4785.17.03027-8. Epub 2017 Sep 20.
Surgery is the elective treatment for cervical relapse from differentiated thyroid cancer (DTC) but it is technically challenging, with risk of failure and morbidity. We explored the feasibility and the efficacy of radioguided occult lesion localization (ROLL) with intratumoral 99mTc radiolabeled human albumin macroaggregates ([99mTc]MAA) injection in this setting.
Fifteen patients who underwent ROLL by ultrasonography (US)-guided intratumoral injection of [99mTc]MAA between December 2013 and October 2016 for DTC recurrence were considered for this study. A hand-held gamma-probe was employed for intrasurgical lesion detection. Mini-invasive ROLL-guided excision for soft tissue recurrence and ROLL-assisted modified radical neck dissection for lymph-node metastases were performed respectively.
DTC recurrence was located in loco-regional lymph-nodes (N.=8 patients) and in thyroid bed (N.=7 patients). A total of 27 lesions was identified and injected before surgery. On a total of 124 lesions resected, histology showed 38 DTC metastases. In particular, 26 out of 27 lesions injected with [99mTc]MAA were correctly detected intra-operatively and resected without surgical complications. Ten patients received subsequent radioactive iodine (RAI) treatment to verify the complete recurrence resection. At a median follow-up of 16 months patients were classified in complete response (N.=4), biochemical incomplete response (N.=3), indeterminate response (N.=1) with no evidence of structural disease. The remaining 7 patients were classified as structural incomplete response for cervical persistent disease (N.=2), for cervical recurrence (N.=2) and for both cervical and lung metastases progression (N.=3).
ROLL is a simple and safe procedure in the surgical management of DTC loco-regional relapse.
手术是分化型甲状腺癌(DTC)颈部复发的首选治疗方法,但技术难度大,有失败和发病的风险。我们探讨了超声引导下瘤内注射放射性胶体([99mTc]MAA)定位隐匿性病灶(ROLL)在这种情况下的可行性和疗效。
2013 年 12 月至 2016 年 10 月期间,15 例 DTC 复发患者接受了超声引导下瘤内注射[99mTc]MAA 进行 ROLL,考虑到本研究。术中采用手持伽马探针检测病灶。分别进行微创 ROLL 引导下软组织复发病灶切除和 ROLL 辅助改良根治性颈淋巴结清扫术。
DTC 复发位于局部淋巴结(N.=8 例)和甲状腺床(N.=7 例)。共确定并注射了 27 个病灶。在总共切除的 124 个病灶中,组织学显示 38 个 DTC 转移。特别是,27 个注射[99mTc]MAA 的病灶中有 26 个在术中被正确检测到并切除,没有手术并发症。10 例患者接受放射性碘(RAI)治疗以验证完全复发切除。在中位随访 16 个月时,患者被分为完全缓解(N.=4)、生化不完全缓解(N.=3)、不确定缓解(N.=1),无结构性疾病证据。其余 7 例患者因颈部持续性疾病(N.=2)、颈部复发(N.=2)和颈部及肺转移进展(N.=3)被归类为结构性不完全缓解。
在 DTC 局部复发的外科治疗中,ROLL 是一种简单、安全的方法。